Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

Maura Pugliatti; Hans-Peter Hartung; Celia Oreja-Guevara; Carlo Pozzilli; Laura Airas; Mona Alkhawajah; Nikolaos Grigoriadis; Melinda Magyari; Bart Van Wijmeersch; Magd Zakaria; Ralf Linker; Andrew Chan; Patrick Vermersch; Thomas Berger

doi:10.3389/fimmu.2022.1045101

Back

Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

Journal article

Open access

Peer reviewed

Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

Maura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, Carlo Pozzilli, Laura Airas, Mona Alkhawajah, Nikolaos Grigoriadis, Melinda Magyari, Bart Van Wijmeersch, Magd Zakaria, …

Frontiers in immunology, Vol.13, pp.1045101-1045101

17/10/2022

DOI: https://doi.org/10.3389/fimmu.2022.1045101

PMID: 36325318

Abstract

adverse events

COVID-19

disease modifying therapies

immune response

Immunology

multiple sclerosis

SARS-CoV-2

vaccines

It has been over a year since people with multiple sclerosis (pwMS) have been receiving vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With a negligible number of cases in which vaccination led to a relapse or new onset MS, experts around the world agree that the potential consequences of COVID-19 in pwMS by far outweigh the risks of vaccination. This article reviews the currently available types of anti-SARS-CoV-2 vaccines and the immune responses they elicit in pwMS treated with different DMTs. Findings to date highlight the importance of vaccine timing in relation to DMT dosing to maximize protection, and of encouraging pwMS to get booster doses when offered.

Files and links (1)

url

https://doi.org/10.3389/fimmu.2022.1045101View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Creators - without role: Maura Pugliatti - University of Ferrara
Hans-Peter Hartung - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Celia Oreja-Guevara - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Carlo Pozzilli - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Laura Airas - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Mona Alkhawajah - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Nikolaos Grigoriadis - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Melinda Magyari - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Bart Van Wijmeersch - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Magd Zakaria - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Ralf Linker - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Andrew Chan - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Patrick Vermersch - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Thomas Berger - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Publication Details: Frontiers in immunology, Vol.13, pp.1045101-1045101
Publisher: Frontiers Media S.A
Identifiers: 9913715408331
Academic Unit: Alfaisal University
Language: English
Resource Type: Journal article